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Cellular/Molecular
PKA Phosphorylation of NDE1 Is DISC1/PDE4 Dependent
and Modulates Its Interaction with LIS1 and NDEL1
Nicholas J. Bradshaw, Dinesh C. Soares, Becky C. Carlyle, Fumiaki Ogawa, Hazel Davidson-Smith, Sheila Christie,
ShaunMackie, Pippa A. Thomson, David J. Porteous, and J. Kirsty Millar
Medical Genetics Section, Molecular Medicine Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital,
Edinburgh EH4 2XU, United Kingdom
Nuclear distribution factor E-homolog 1 (NDE1), Lissencephaly 1 (LIS1), and NDE-like 1 (NDEL1) together participate in essential
neurodevelopmental processes, including neuronal precursor proliferation and differentiation, neuronal migration, and neurite out-
growth. NDE1/LIS1/NDEL1 interacts with Disrupted in Schizophrenia 1 (DISC1) and the cAMP-hydrolyzing enzyme phosphodiesterase
4 (PDE4). DISC1, PDE4, NDE1, and NDEL1 have each been implicated as genetic risk factors for major mental illness. Here, we demon-
strate that DISC1 and PDE4 modulate NDE1 phosphorylation by cAMP-dependent protein kinase A (PKA) and identify a novel PKA
substrate site on NDE1 at threonine-131 (T131). Homology modeling predicts that phosphorylation at T131 modulates NDE1–LIS1 and
NDE1–NDEL1 interactions, which we confirm experimentally. DISC1–PDE4 interaction thus modulates organization of the NDE1/
NDEL1/LIS1 complex. T131-phosphorylated NDE1 is present at the postsynaptic density, in proximal axons, within the nucleus, and at
the centrosomewhere it becomes substantially enriched duringmitosis. Mutation of the NDE1 T131 site tomimic PKA phosphorylation
inhibits neurite outgrowth. Thus PKA-dependent phosphorylation of the NDE1/LIS1/NDEL1 complex is DISC1–PDE4 modulated and
likely to regulate its neural functions.
Introduction
Nuclear distribution factor E-homolog 1 (NDE1, NUDE), its
paralog NDE-like 1 (NDEL1, NUDEL), and Lissencephaly 1
(LIS1, PAFAH1B1) play cooperative and critical roles in neuro-
nal proliferation, differentiation, and migration within the brain
(Hirotsune et al., 1998; Feng andWalsh, 2004; Sasaki et al., 2005;
Pawlisz et al., 2008). All three bind directly to Disrupted in
Schizophrenia 1 (DISC1) (Millar et al., 2003; Morris et al., 2003;
Ozeki et al., 2003; Brandon et al., 2004; Camargo et al., 2007; Taya
et al., 2007; Burdick et al., 2008; Bradshaw et al., 2009), a scaffold
protein critical to neuronal proliferation, migration, integration,
and synaptic function within the developing and adult brain
(Duan et al., 2007; Faulkner et al., 2008; Kvajo et al., 2008). Phos-
phodiesterase 4 (PDE4) subtypes A–D also bind DISC1 to regu-
late local cAMP levels (Millar et al., 2005a). NDE1, NDEL1, LIS1,
and PDE4 cocomplex with DISC1 (Bradshaw et al., 2008; Collins
et al., 2008), suggesting DISC1 acts as a molecular scaffold that
integrates the cAMPmodulatory activity of PDE4with the neural
functions of NDE1/LIS1/NDEL1.
A large body of genetic evidence supports DISC1 as a major
risk factor for psychiatric illness (Marx, 2007; Chubb et al., 2008),
but the underlying dysfunctional molecular and signaling mech-
anisms involved remain unclear. PDE4B, PDE4D, NDE1, and
NDEL1 have also been implicated as genetic risk factors formajor
mental illness (Millar et al., 2005a; Hennah et al., 2007; Pickard et
al., 2007; Burdick et al., 2008; Fatemi et al., 2008; Numata et al.,
2008; Ingason et al., 2009; Need et al., 2009; Tomppo et al., 2009;
Nicodemus et al., 2010). Moreover, PDE4-specific inhibitors
such as rolipram have antidepressant- and antipsychotic-like
profiles (Maxwell et al., 2004; O’Donnell and Zhang, 2004; Kanes
et al., 2007), whereas novel, allosteric inhibitors of PDE4D are
potential cognitive enhancers (Burgin et al., 2010). Together, this
evidence argues thatmechanisms that alter the complexation and
thus function of these proteins are likely to be relevant to the
pathogenesis of schizophrenia and related psychiatric illness.
Protein phosphorylation provides a means by which protein
function can be rapidly and precisely tuned. Phosphorylation of
NDE1 and/or NDEL1 modulates their protein–protein interac-
tions and subcellular localization (Niethammer et al., 2000;
Toyo-oka et al., 2003, 2005; Yan et al., 2003; Hirohashi et al.,
2006a,b; Hebbar et al., 2008; Shen et al., 2008) and influences
mitotic progression (Mori et al., 2007) and neurite extension
(Mori et al., 2009). We have shown that NDE1 is phosphorylated
by cAMP-activated protein kinase A (PKA) (Bradshaw et al.,
2008), suggesting a link between PDE4, cAMP, and the NDE1/
NDEL1/LIS1 complex. Here, we demonstrate DISC1/PDE4-
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dependent PKA phosphorylation of NDE1 at an additional site,
threonine-131 (T131), which alters its interaction with NDEL1
and LIS1. Furthermore, the T131 site exerts a profound effect on
neurite extension. We propose that DISC1/PDE4-modulated,
PKA-dependent cAMP signaling is a key regulator of NDE1/
NDEL1/LIS1 function in the brain and thus a promising target
for molecular therapeutic intervention.
Materials andMethods
Antibodies. Anti-NDE1 antibody EP93 (Bradshaw et al., 2009) and anti-
DISC1 antibody -DISC1 (Ogawa et al., 2005) have been described pre-
viously; the latter was a gift from Prof. T. Akiyama (University of Tokyo,
Tokyo, Japan). For some tests, EP93 was conjugated to an Alexa Fluor
fluorescent tag (Invitrogen). Anti-NDEL1 antibody (231) was a gift from
Dr. N. Brandon (Merck, Sharp & Dohme, Harlow, UK; now at Pfizer,
Groton, CT). Antibodies EP94 and EP95 were raised against the mouse
Nde1 peptides MTYKQRAENTQE and GKRLEFGKPASEPAS, re-
spectively, purified by Eurogentec, and selected based on their lack of
homology with mouse Ndel1. Antibody pT131 was raised against the
phosphorylated (at residue marked “p”) human NDE1 peptide
CDLERAKRA(pT)IM and purified to detect this peptide but not the
nonphosphorylated peptide CDLERAKRATIM by Eurogentec. Anti-
bodies against DISC1 C terminus (Zymed Laboratories), GAPDH
(Millipore Bioscience Research Reagents), GFP (Roche), GST (GE
Healthcare), LIS1 (Sigma), MAP2 (Abcam), NDE1/NDEL1 (raised
against NDE1 but also detects NDEL1; Abnova) (Bradshaw et al.,
2009), PSD-95 (ABR–Affinity BioReagents), TUJ1 (Covance), and V5
(Invitrogen) were also used. An anti-PKA substrate antibody (Cell
Signaling Technology) was raised against the phosphorylated peptide
RRX(pS/T), but according to the manufacturer also detects the motif
KRX(pS/T).
Plasmid constructs. We have previously described the constructs
pDEST40NDE1, pDEST40NDEL1, pDEST53NDEL1, pGEX6PINDEL1
(Bradshaw et al., 2009), and pDEST40NDE1-S306A (Bradshaw et al.,
2008) that express the NDE1-SSSC or NDEL1-PLSV isoforms, as well as
the DISC1 truncation construct pEBG2TDISC1(359–854) (Murdoch et
al., 2007). Additional mutant NDE1 constructs were generated using
the QuikChange II Site Directed Mutagenesis kit (Stratagene) and the
following primers: T131A, GGAAAGAGCCAAGCGGGCTGCGAT-
CATGTCTCTCGAAG, CTTCGAGAGACATGATCGCAGCCCG-
CTTGGCTCTTTCC; T131E, GGAAAGAGCCAAGCGGGCTGAGAT-
CATGTCTCTCGAAG, CTTCGAGAGACATGATCTCAGCCCGCT-
TGGCTCTTTCC; S306D, GAGACGGCCAAGCGATACCAGCGT-
GCCTTTG, CAAAGGCACGCTGGTATCGCTTGGCCGTCTC. The
construct pEBG2TDISC1 was created in the following way. To enable
recloning of the DISC1ORF (L isoform), we ablated the internal BamH1
site using the QuikChange II kit (Stratagene) using the following prim-
ers: sense primer, 5-S:TCCTCCAGTTCTCTCGATCCCTCACTG-
GCTGGC; antisense primer, 5-AS:GCCAGCCAGTGAGGGATCGA-
GAGAACTGGAGGA. The DISC1 ORF (amino acids 2–854) was then
reamplified using BamHI 5-GATCGGATCCCCAGGCGGGGGTCCT-
CAGGGC-3 and Not1 5-GATCGCGGCCGCTCAGGCTTGT-
GCTTCGTGGACACCAGC amplimers using Pfu Ultra DNA polymerase
(Stratagene) and transferred topEBG2Tusing standardmolecular biologypro-
cedures. All constructswere verified byDNAsequencing.
Cell culture. COS7, HEK293, and SH-SY5Y cells were cultured and
transfected as described previously (Bradshaw et al., 2009). In some in-
stances, cells were incubated with 100 M forskolin, 250 M IBMX,
and/or 10 M rolipram (Sigma) in DMEM (Invitrogen) for 30 min im-
mediately before harvesting lysates. Neuroscreen-1 (NS-1) cells were cul-
tured, transfected, and had neurite outgrowth induced as described
previously (Gru¨newald et al., 2009). Primary mouse cortical and hip-
pocampal neurons were prepared, cultured, and transfected as described
previously (Bradshaw et al., 2008).
Production of the DISC1-overexpressing cell line, TRTODISC1, was
described in detail previously (Carlyle et al., 2011). Briefly, the T-Rex
Tet-On system (Invitrogen) was used to express full-length human
DISC1 in SH-SY5Y in a tetracycline-inducible manner. Colonies were
selected using Blasticidin and Zeocin, with DISC1 expression confirmed
by Western blotting and real-time PCR.
Immunofluorescence. Immunofluorescence was performed according
to standard protocols (Millar et al., 2005b). Coverslips were viewed on
either an Axioskop 2 or LSM510 confocal microscope (Zeiss).
Neurite outgrowth assay. NS-1 cells were transfected and had neurite
outgrowth induced as described previously (Gru¨newald et al., 2009),
with the pDEST40NDE1, pDEST40NDE1-T131A, or pDEST40NDE1-
T131E construct. The researcher performing all experimental procedures
and measurements for this assay was blinded as to which construct had
been transfected into each set of cells. Cells were then stained for immu-
nofluorescence with the EP93 and TUJ1 antibodies. EP93 was used to
identify transfected cells, whereas TUJ1 was used to visualize the entire
cell body and neurites. Images were viewed using ImageJ (http://rsbweb.
nih.gov/ij). Sholl analysis was then performed (Sholl, 1953) using the
Concentric Circles plug-in (http://rsbweb.nih.gov/ij/plugins/concentric-
circles.html). For each cell, the number of neurite outgrowths (defined as
any protrusion from the cell body) that intersectedwith each of a series of
circles, 10 m apart and centered on the cell body, was measured. The
“total neurite outgrowth length” in micrometers in each cell was derived
Figure 1. Effect of PDE4 and DISC1 on PKA phosphorylation of NDE1. A, COS7 cells were
transfected with V5-tagged NDE1 and treated with rolipram and/or forskolin in two indepen-
dent experiments. The expressed NDE1 was then immunoprecipitated using an anti-V5 anti-
body. Top, Detection of PKA phosphorylation in the anti-V5 immunoprecipitate using an
antibody that detects the amino acid sequence (R/K)RX(S/T), the canonical target site for phos-
phorylation by PKA, but only when the serine/threonine is phosphorylated. This demonstrates
thepresenceof aPKA-phosphorylated species in the immunoprecipitate. Bottom,NDE1 loading
control detected using the V5 antibody demonstrates that the PKA-phosphorylated species
detected in the top panel conforms to the molecular weight of V5-tagged NDE1 and that ap-
parent changes in phosphorylation are not caused by variation in the level of total V5-NDE1. B,
COS7 cells were transfected with V5-tagged NDE1, with or without GST-tagged DISC1. Top,
Detection of PKA phosphorylation in anti-V5 immunoprecipitates using the PKA substrate an-
tibody. Bottom,NDE1 loading control detected using the V5 antibody. C, Densitometric analysis
of three independent experiments as described in B. D, COS7 cells were transfected with V5-
tagged NDE1 plus GST-tagged DISC1 (either full length or amino acids 359–854 only). Top,
Detection of PKA phosphorylation in anti-V5 immunoprecipitates using the PKA substrate an-
tibody. An additional novel,40 kDa PKA-phosphorylated species (asterisk) is also immuno-
precipitated. Thismaybe anNDE1-interacting protein that is also PKAphosphorylated. Bottom,
NDE1 loading control detected using the V5 antibody. E, Densitometric analysis of three inde-
pendent experiments as described in D. F, PDE4 activity assays in the inducible DISC1-
expressing cell line TRTODISC1 with or without forskolin treatment.
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by summing the number of intersections at all of the circles. The maxi-
mum length of the cell body was measured, along with its maximum
width along any line perpendicular to this. The ratio of these values was
used to model the degree of elongation of the cell, whereas their product
multiplied by /4 was used as an approximation for the cross-sectional
area of the cell body in square micrometers. The number of primary
neurites leaving the cell body, along with the number of “branch points”
at which primary neurites diverged to form secondary neurites, was also
counted. Numbers of neurite outgrowths intersecting each Sholl circle,
along with the other measurements taken, were analyzed by two-tailed,
unpaired t tests. The Sholl analysis data set as a whole was analyzed by
modeling the effect of the type of NDE1 construct (wild type or type of
mutant) transfected into the cell on the number of neurite outgrowths
intersecting each Sholl circle using general linear model repeated mea-
sures (SPSS) with the construct type and cell identification numbers as
factors.
Immunoprecipitation and immunoblotting. Immunoprecipitation
from cell lysates (Bradshaw et al., 2008) and subsequent immunoblotting
(James et al., 2004) was performed according to standard protocols. In
some experiments, the signal strength was quantified by densitometry
using ImageJ (http://rsbweb.nih.gov/ij). Unless otherwise stated, all such
datawas analyzed using two-tailed, paired t tests. Dot blot was performed
by blotting 2l of peptide (Eurogentec) onto a nitrocellulose membrane
(Invitrogen) and leaving it to dry at room temperature. Total protein was
visualized using 0.5% Ponceau S/2% acetic acid.
Preparation of postsynaptic density fractions. Postsynaptic density frac-
tions were isolated from mouse brain homogenates as described previ-
ously (Clapcote et al., 2007).
In vitro PKA phosphorylation. GST or GST-tagged NDEL1 was ex-
pressed, purified, and treated with recombinant PKA (Promega) as de-
scribed previously (Bradshaw et al., 2008). For peptide phosphorylation,
50 mg/ml peptide (Eurogentec) was mixed with an equal volume of 208
g/ml recombinant PKA catalytic domain (Promega) in 80 mM Tris-
HCl, pH 7.4/40mMmagnesium acetate/4MATP and incubated at 30°C
for 7min. H89was added at 500 nM either at the start of the reaction or to
terminate it. Two microliters of the reaction product (50 g peptide)
were then dot blotted.
Phosphodiesterase assay. Phosphodiesterase activity in cell lines was
assayed using a variation on the protocol of Marchmont and Houslay
(1980). TRTODISC1 cells were grown to70% confluency in T25 flasks.
Flasks were incubated in DMEM/5% fetal bovine serum with or without
1 g/ml tetracycline for 24 h, rinsed, and incubated in DMEM for 16 h.
Figure 2. T131 as a novel PKA substrate site on NDE1 and localization pattern of phosphor-
ylated NDE1. A, COS7 cells were transfected with V5-tagged NDE1, either wild type (WT) or
mutated. PKA phosphorylation of NDE1 in anti-V5 immunoprecipitates were examined on im-
munoblots using an anti-PKA substrate antibody in three independent experiments. Top, PKA
phosphorylation detected using the PKA substrate antibody. Bottom, NDE1 loading control
detected using the V5 antibody. The arrow marks NDE1 signal. B, Top, The pT131 antibody
detects an NDE1 peptide, CDLERAKRA(pT)IM, containing phosphorylated T131, but does not
recognize an otherwise identical unphosphorylated peptide. Bottom, Ponceau S loading con-
trol. The contrast was adjusted uniformly using Adobe Photoshop for clarity. C, Top, the pT131
antibody detects an endogenous NDE1-sized protein species in HEK293 lysates. This species is
more abundant in cells that have been treated with IBMX plus forskolin to raise cellular cAMP
levels and enhance PKA activity. Bottom, GAPDH loading control.D, Top, The signal detected by
the pT131 antibody in COS7 cells treatedwith IBMX plus forskolin is reduced by treatment with
the PKA-specific inhibitor H89. Bottom, NDE1 loading control detected using antibody EP93.
E, The pT131 antibody detects the NDE1 peptide CDLERAKRATIM (T131 in italics) after incuba-
tion with recombinant PKA in vitro. This effect is inhibited by the PKA inhibitor H89. Bottom,
4
Ponceau S loading control. The contrast was adjusted uniformly using Adobe Photoshop for
clarity. F, The pT131 antibody (red) and the anti-NDE1 EP93 antibody (green) both detect the same
signal at the centrosomeandnucleus of COS7 cells by confocalmicroscopy. Scale bar, 10m.
Figure 3. The effect of rolipram and DISC1 on individual PKA substrate sites of NDE1. A, The
relative increase in phosphorylation of V5-tagged NDE1 caused by application of rolipram plus
forskolin, compared with forskolin alone, is decreased when either the T131 or S306 residue of
NDE1 is mutated to alanine. Densitometric analysis of three independent Western blot experi-
ments is shown.B, The increase in phosphorylation of V5-tagged NDE1 caused by expression of
GST-DISC1 compared with GST alone is only subtly decreased when either the T131 or S306
residue ofNDE1 ismutated to alanine, although this ismore pronouncedwhenadoublemutant
is used. Densitometric analysis of three independent Western blot experiments is shown.
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Forskolin (or an equivalent volume vehicle)
was added to 10 M, and flasks were incubated
for 30min at 37°C. Cells were lysed with 25mM
HEPES, pH 7.5/2.5 mM EDTA/50 mMNaCl/50
mM NaF/30 mM sodium pyrophosphate/10%
glycerol/1% Triton X-100 with protease
(Roche), and phosphatase (Calbiochem) in-
hibitor mixtures. Lysates were diluted to 0.4
g/l with pH7.5 Tris solution to a total of 50
l, with and without 10M rolipram. Fifty mi-
croliters of each lysate were mixed, in triplicate
with 50 l of 20 mM Tris-HCl, pH 7.4/2 M (3
Ci [ 3H]/ml) cAMP/10 mM MgCl2. Reactions
were vortexed, spun down, incubated at 30°C
for 10 min, and terminated by boiling for 2
min. Tubes were removed to ice for 15 min,
and 25 l of Western Diamondback snake
venom (Sigma) was added to 1 mM. The mix-
turewas incubated at 30°C for 10min, inwhich
the [ 3H]-labeled cAMP hydrolysis product,
5AMP, is dephosphorylated to adenosine by
the snake venom. The negatively charged non-
hydrolyzed cAMP was separated out of the re-
action mixture by an additional 400 l of
Dowex ion exchange resin (made up to slurry
1:1:1 Dowex/water/absolute alcohol; Sigma).
Reactions were left to stand for 15 min with
inversion every 5 min, followed by centrifuga-
tion at 14,000 rpm for 3min.One hundred fifty
microliters of the supernatant were carefully
removed and added to 1 ml of Ecoscintillant
fluid, and tubes were inverted and read on a
scintillation counter. PDE4-specific activity is
calculated by the subtraction of non-PDE4
activity (the component remaining in the
rolipram-treated replicates) from the total ac-
tivity measured in the assay.
Homology modeling. Modeling of human
NDE1 was undertaken using Modeller version
9.7 (Sali and Blundell, 1993; Fiser and Sali,
2003) based on the template fragments of
NDEL1 solved by crystallography (Derewenda
et al., 2007) and deposited in the Protein Data
Bank (PDB) (Berman et al., 2000), i.e., the
shorter fragment (regions 58–168) 2.1 Å reso-
lution x-ray protein structure of human
NDEL1 (PDB identification 2V66, chains
B–E); the longer (regions 8–167) 2.24 Å reso-
lution x-ray protein structure of rat NDEL1
(PDB identification 2V71, chains A and B; the
rat amino acid sequence is identical to the hu-
man protein for the region of coiled coil
solved). Note that althoughNDEL1 is reported
to be dimeric in solution, both crystal struc-
tures (solved under different conditions, inde-
pendently) portray a tetrameric structure. For
rat NDEL1 8–167, the dimer–dimer interface
is between unit cells, whereas for human
Figure 4. NDEL1 crystal structures and NDE1 homology-derived three-dimensional models. A–C, The high-resolution NDEL1
coiled-coil crystal structures (at various levels of zoom) showing the location and inter-side-chain and intra-side-chain H-bonding
network of T132 with neighboring amino acid residues within the short tetramer (PDB identification 2V66) (A), long tetramer
generated using symmetry operations (PDB identification 2V71) (B), and long dimer (PDB identification 2V71) (C). Chains and
residues are colored and labeled independently, and H-bonding (dashed lines) distances are shown in angstroms. D, Homology-
based three-dimensional models of NDE1 show intact wild type (T131) for each equivalent oligomeric state for the coiled-coil
regions (left, short tetramer; middle, long tetramer; right, long dimer), generated from the three NDEL1 templates. E, The T131A
4
NDE1 SCWRL models (close-up fragment view of the three
models; left, short tetramer;middle, long tetramer; right, long
dimer) with corresponding hydrophobic interactions of A131
is shown. F, The T131E NDE1 SCWRL models, close-up frag-
ment view arranged as in E revealing unsatisfactory close con-
tacts between corresponding E131 side chains [some of these
“close-contact” distances are shown in angstroms (red dashed
lines) and should not to be mistaken for H-bonds].
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NDEL1 58–168, the tetramer lies within the unit cell. Thus, there are
already four chains present within the deposited human NDEL1 58–168
structure, whereas a tetrameric version of rat NDEL1 8–167 (to give
chains A–D) was generated with symmetry operations applied using the
PISA server (Krissinel and Henrick, 2007), separately, because only two
chains of the dimeric version (chainsA andB)were deposited in the PDB.
Three NDE1 models were built based on the (shorter) human NDEL1
tetramer, the (longer) rat NDEL1 dimer, and the tetramer of the (longer)
rat sequence generated by symmetry operations. The target, NDE1,
shares 75 and 71% sequence identity, over the equivalent coiled-coil
regions, with the human (58–168) and rat (8–167) NDEL1 templates,
respectively. The alignment between the target and template sequences
created for modeling purposes was based on a multiple-sequence align-
ment among related proteins (see supplemental Fig. 1, available at
www.jneurosci.org as supplemental material) using the program Clust-
alX (Thompson et al., 1997). There exist no residue gaps between target
and template sequences over the alignment length used for modeling.
Thirty models were generated using Modeller version 9.7, and the ones
with the lowest objective function score (Sali and Blundell, 1993) or with
least deviation from the template were selected as the representative
NDE1 models in each case. The models were checked for valid stereo-
chemistry using PROCHECK, and, additionally, packing quality was as-
sessed using WHAT IF (Vriend, 1990; Vriend and Sander, 1993). Side-
chain replacement was performed using SCWRL version 4 (Krivov et al.,
2009), and the resulting in silicomutated models were assessed for pack-
ing and close contacts under PyMol (DeLano Scientific), PROCHECK,
and WHAT IF. The Protein Interactions Calculator was used to infer
intramolecular and intermolecular interactions (Tina et al., 2007), and
solvent-accessibility calculations were performed using GETAREA
(Fraczkiewicz and Braun, 1998).
Results
PKA phosphorylation of NDE1 is modulated by PDE4
and DISC1
We recently demonstrated that NDE1 is a target of the cAMP-
dependent kinase PKA and that it cocomplexes with DISC1 and
the cAMP-hydrolyzing enzyme PDE4 (Bradshaw et al., 2008).
We therefore tested whether PDE4 modulates PKA phosphory-
lation of exogenously expressed V5 epitope-tagged NDE1
through regulation of local cAMP levels. In COS7 cells, treatment
with forskolin, an activator of adenylyl cyclase, leads to increased
phosphorylation of exogenous V5-NDE1 (Fig. 1A). Coapplica-
tion of rolipram, a specific PDE4 inhibitor, dramatically increases
this effect (Fig. 1A), indicating that PDE4 can indeed modulate
the phosphorylation status of NDE1.
Given that PDE4 and NDE1 are both DISC1-interacting
proteins, we postulated that DISC1 may modulate PKA phos-
phorylation of NDE1 via regulation of PDE4 activity. First,
full-length DISC1 was coexpressed with V5-NDE1 in COS7
cells. Cells were then treated with forskolin plus IBMX, a non-
specific inhibitor of phosphodiesterases, to increase PKA ac-
tivity. The level of V5-NDE1 phosphorylation by PKA in the
presence of high levels of exogenous DISC1 consistently in-
creases relative to expression of V5-NDE1 alone (Fig. 1B),
although the level of increase is highly variable (Fig. 1C). To
determine whether the effect of DISC1 on V5-NDE1 is attrib-
utable in part to its interaction with PDE4, V5-NDE1 was
coexpressed in COS7 cells with DISC1 lacking the N-terminal
358 amino acids, with IBMX and forskolin treatment. These
residues specify four of the contact sites for PDE4B, and their
removal reduces PDE4B interaction with DISC1 (Millar et al.,
2005a; Murdoch et al., 2007). Overexpression of the truncated
form results in increased PKA phosphorylation of V5-NDE1
(p  0.03) (Fig. 1D,E), suggesting that DISC1 can influence
NDE1 phosphorylation by modulating PDE4 activity.
To investigate this further, we used a modified SH-SY5Y hu-
man neuroblastoma cell line, TRTODISC1, which overexpresses
DISC1 after treatment with tetracycline. Using this cell line, we
assayed the effect of elevated DISC1 expression on endogenous
PDE4 activity. It is known that forskolin-stimulated elevation of
cellular cAMP results in PKA-mediated activation of PDE4 long
isoforms (MacKenzie et al., 2002). As expected, in the uninduced
TRTODISC1 cell line, forskolin increases PDE4 activity by20%
comparedwith the vehicle-treated control (Fig. 1F). Induction of
DISC1 overexpression does not affect basal PDE4 activity but
blocks the increase in PDE4 activity that would otherwise fol-
low forskolin treatment (Fig. 1F). DISC1 can therefore mod-
ulate PDE4 activity by suppressing its ability to react to
Figure 5. Effect of PKA phosphorylation of NDE1 on NDE1/LIS1 and NDE1/NDEL1 protein
interactions. A, COS7 cells were transfected with V5-tagged NDE1, either wild type or mutant,
and treated with IBMX plus forskolin. Top, Coimmunoprecipitation of endogenous LIS1. The
arrow marks LIS1 signal. Bottom, NDE1 loading control detected using the V5 antibody. B,
Densitometric analysis of five independent experiments as described in A. C, COS7 cells were
transfected with wild-type V5-tagged NDE1 and treated with IBMX/forskolin (Fsk). Top, Coim-
munoprecipitation of endogenous LIS1. Bottom, NDE1 loading control detected using the V5
antibody to reprobe the same blot. D, Densitometric analysis of four independent experiments
as described in C. E, COS7 cells were transfected with V5-tagged NDE1, either wild type or
mutant, plusGFP-taggedNDEL1. Top, Coimmunoprecipitationof GFP-NDEL1 (predicted size, 71
kDa) detected using a GFP-specific antibody. The 50 kDa band (asterisk) represents IgG.
Bottom, NDE1 loading control detected using the V5 antibody. F, Densitometric analysis of five
independent experiments as described in E. WT, Wild type.
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increased cAMP concentrations, and
this is the likely route by which DISC1
exerts its effect on PKA phosphorylation
of NDE1.
PKA phosphorylation of NDE1 at T131
Previously, we demonstrated phosphory-
lation of NDE1 by PKA at serine-306
(S306), although our data indicated the
existence of additional PKA phosphoryla-
tion sites on NDE1 (Bradshaw et al.,
2008). According to the amino acid se-
quence analysis program Scansite 2.0
(Obenauer et al., 2003), the next most
highly predicted candidate PKA substrate
site is T131.
Constructs encoding V5-NDE1 were
generated, where either one or both of
S306 and T131 were substituted for ala-
nine, thus preventing phosphorylation of
these residues. COS7 cells were trans-
fected with alanine substitution mutants
or the wild-type form of V5-NDE1. To
raise the cellular cAMP concentration and
increase PKA activity, transfected cells
were treated with forskolin and IBMX.
V5-NDE1 was immunoprecipitated using
anti-V5 antibody. The level of NDE1 PKA
phosphorylation was assayed on immu-
noblots using an antibody raised against
phosphorylated PKA substrate sites. We
have shown previously that a single S306A
mutation causes a more than twofold
reduction in the level of NDE1 phosphor-
ylation whenmeasured in this way (Brad-
shaw et al., 2008), but no such effect was
seen with the single T131A mutation when
compared with wild-type NDE1 (Fig. 2A).
The V5-NDE1-T131A/S306A double mu-
tant, however, consistently shows less phos-
phorylation than the S306A single mutant
(Fig. 2A). It is therefore probable that T131
is aPKAphosphorylation site onNDE1, but
utilization of the S306 phosphorylation site
masks the effect of T131 in this assay, be-
cause of the S306 site bearing a closer simi-
larity than T131 to the phosphorylated
motif against which the PKA substrate anti-
body was raised.
To explore this further, an antibody
(pT131) was raised against an NDE1
phosphopeptide spanning the T131 site.
This antibody exhibits clear specificity
for the peptide containing phosphory-
lated T131 (Fig. 2B), and detects a sub-
set of V5-NDE1 when over-expressed in COS7 (see
supplemental Fig. 2A, available at www.jneurosci.org as sup-
plemental material). The pT131 antibody detects an endoge-
nous NDE1-sized protein species of 38 kDa in HEK293 and
COS7 that is enhanced in lysates treated with IBMX plus for-
skolin and depleted by the PKA-specific inhibitor H89 (Fig.
2C,D). These same effects of forskolin and H89 are seen in
mouse cortical neurons (see supplemental Fig. 2B–E, available
at www.jneurosci.org as supplemental material). H89 also re-
duces the pT131 signal detected when a nonphosphorylated
NDE1 peptide containing the T131 site is treated with recom-
binant PKA in vitro (Fig. 2E). In COS7 cells, the pT131 signal
colocalizes prominently with that of endogenous NDE1 at the
nucleus and centrosome and weakly in the cytoplasm (Fig.
2F). Thus, T131 is a physiologically active PKA phosphoryla-
tion site.
A
B
C
D
E
F
Figure 6. Localization of PKA-phosphorylated NDE1/NDEL1 (antibody pT131) and-tubulin, in mitotic COS7 cells. Scale bars,
10m. White arrows indicate the centrosome or individual centrioles, as appropriate. A, Interphase; B, prophase; C, prometa-
phase; D, metaphase; E, anaphase; F, telophase.
9048 • J. Neurosci., June 15, 2011 • 31(24):9043–9054 Bradshaw et al. • PKA Phosphorylation of NDE1
Given the high degree of similarity between NDE1 and
NDEL1 in the region surrounding T131 (see supplemental Fig.
3A, available at www.jneurosci.org as supplementalmaterial), the
pT131 antibody should also detect NDEL1 if it is phosphorylated
on its corresponding residue, T132. Consistent with a previous
report (Collins et al., 2008), although we could phosphorylate
NDEL1with recombinant PKA in vitro (see supplemental Fig. 3B,
available at www.jneurosci.org as supplemental material), we
have been unable to demonstrate NDEL1 phosphorylation by
PKA when expressed in COS7 (see supplemental Fig. 3C, avail-
able at www.jneurosci.org as supplemental material). However,
this does not rule out the possibility that NDEL1 is a substrate of
PKA in vivo, thus the pT131 antibody cannot distinguish phos-
phorylation of endogenous NDE1 from endogenous NDEL1.
PKA phosphorylation sites T131 and S306 are modulated by
PDE4 and DISC1
Since PKA phosphorylation of NDE1 is upregulated by both
DISC1 overexpression and PDE4 inhibition (Fig. 1), we next ex-
aminedwhether DISC1/PDE4modulates the T131 or S306 phos-
phorylation sites. In forskolin-treated COS7 cells expressing
either the T131A or S306A phosphomutant, the rolipram-
induced increase in NDE1 PKA phosphorylation is consistently
and significantly attenuated (Fig. 3A) (p  0.02 for T131A, p 
0.008 for S306A). Consistent with its effect in COS7 cells, rolip-
ram also alters the level of pT131 signal in primary neurons (see
supplemental Fig. 2D,E, available at www.jneurosci.org as sup-
plemental material). Mutation of either PKA phosphorylation
site individually in IBMX/forskolin-treatedCOS7 cells also atten-
uates the DISC1 overexpression-induced
increase in NDE1 PKA phosphorylation,
although the modulatory effect of DISC1
on both sites is subtle compared with the
modulatory effect of PDE4. Using the
double-phosphomutant T131A/S306A,
there is a significant reduction in the level
of total PKA phosphorylation of NDE1 in
response to DISC1 overexpression (Fig.
3B) (p 0.005), confirming that usage of
both sites is indeed modulated by DISC1,
although intriguingly, 60% of the
DISC1-induced increase in NDE1 phos-
phorylation by PKA is not accounted for
by the T131 and S306 sites (Fig. 3B), indi-
cating the presence of an additional site(s)
on NDE1 that will be the focus of future
investigations. Notwithstanding the addi-
tional site(s), our data demonstrate that
DISC1 and PDE4 both modulate phos-
phorylation of T131 and S306, consis-
tent with our observation that DISC1
regulates PDE4 activity (Fig. 1F).
Three-dimensional modeling of NDE1
based on crystal structures of NDEL1
To predict likely effects of PKA phosphor-
ylation on NDE1 function, we performed
in silico homology modeling of NDE1
based on known structures of NDEL1
(Derewenda et al., 2007). Three models
were built based on (1) the (shorter) hu-
man NDEL1 tetramer, (2) the (longer)
rat NDEL1 dimer, and (3) the derived
tetramer of the (longer) rat sequence generated by symmetry
operations (see Materials and Methods for more details; struc-
tural coordinate files are available from the authors on request).
The target, NDE1, shares 75 and 71% sequence identities over the
equivalent regions within the human (58–168) and rat (8–167)
NDEL1 templates, respectively, enabling a straightforward mod-
eling exercise.
T132 in NDEL1 is completely buried in the tetrameric (2V66)
crystal structure of the 58–168 construct (Fig. 4A), whereas it is
exposed in the dimeric (2V71) 8–167 construct (Fig. 4B). It is
also exposed in the symmetry operation-generated tetrameric
(8–167) structure (Fig. 4C), although it faces opposing helices
and is not readily accessible. T131 in NDE1 is similarly predicted
to be buried in the shorter NDE1 tetramer (modeled on NDEL1,
PDB identification 2V66) and exposed in both the longer NDE1
dimer and longer NDE1 tetramer (modeled on the two NDEL1
templates, PDB identification 2V71) (Fig. 4D).
From the NDE1 in silicomutant models (T131E, phosphory-
lation mimic), it is clear that phosphorylation of T131 would
decrease the packing of side chains at the coiled-coil interface,
which would result in a less stable, more open interface between
interacting helices. Another issue is placement of the phosphor-
ylated T131 side chain in close proximity to equivalent phosphate
groups from the other NDE1 molecules. This would be disfa-
vored by mutual repulsive effects of negatively charged groups.
Consequently, in order for phosphorylation at T131 to be
energetically viable, the helices would be required to unwind
(or open out at their helical interfaces) to allow for formation
of H-bonds in the T131E model. Furthermore, additional
A
B
C
Figure 7. Phosphorylated T131/T132within neurons. A, The pT131 antibody detects phosphorylated NDE1/NDEL1 in postsyn-
aptic density fractions (PSD1–3) and is enriched in the core PSD3 fraction compared with the synaptosomal fraction (Syn). PSD1
was yielded after extraction once with Triton X-100, PSD2 was yielded after extraction twice with Triton X-100, and PSD3 was
yielded after extraction with Triton X-100 once and thenwith N-lauroylsarcosinate. Phosphorylated NDE1 is seen principally as an
50 kDa species (arrow), which is also detected using two anti-murine NDE1 antibodies, EP94 and EP95. The canonical40 kDa
NDE1 species (asterisk) is also seen with these two antibodies. Blots were visualized using alkaline phosphatase-conjugated
antibodies and BCIP/NBT. B, The pT131 antibody signal (green) colocalizes with PSD-95 (red) in primary mouse hippocampal
neurons (23 d in vitro) by confocal microscopy. Enlargements of the boxed regions are displayed. C, pT131 antibody signal (green)
is enriched within proximal axons (white arrows) of both immature (9 d in vitro; top) and mature (23 d in vitro; bottom) primary
mouse hippocampal neurons. Axons are defined as major neurites that do not display MAP2 staining (red). Scale bars, 10m.
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steric clashes/bad contacts (defined by nonbonded atoms at a
distance of 2.6Å) occur in these mutated models but not in
the T131A (nonphosphorylation) form of NDE1 (Fig. 4E,F ).
Given that the region encompassing T131 is involved in bind-
ing to LIS1 (Feng et al., 2000), phosphorylation of this residue
may influence NDE1/LIS1 interaction. Moreover, it could also
affect any heterodimerization or heterotetramerization that
may take place between NDE1 and NDEL1 via their very
highly conserved region 3. A more detailed description and
discussion of the NDE1 modeling analysis can be found in the
supplemental material (available at www.jneurosci.org).
PKAmodulates association of NDE1 with LIS1 and NDEL1
To test the molecular modeling prediction that PKA phosphory-
lation ofNDE1 at T131modulatesNDE1/LIS1 interaction, COS7
cells were transfected with constructs encoding V5-NDE1, either
wild type or bearing the T131A (nonphosphorylatable) or T131E
(phosphomimic) mutation. The T131A mutation is not pre-
dicted to influence the structure of NDE1, whereas T131E is pre-
dicted to affect coiled-coil formation in a similar manner to
phosphorylation (Fig. 4E,F) (detailed analysis in the supplemen-
tal material, available at www.jneurosci.org). The level of endog-
enous LIS1 coimmunoprecipitationwithNDE1was then assayed
after treatment with IBMX/forskolin. LIS1 associates signifi-
cantly less with the NDE1-T131E phosphomimic mutant than
wild-type NDE1 or the T131Amutant (p 0.003 and p 0.004,
respectively) (Fig. 5A,B). There is no significant difference be-
tween coimmunoprecipitation of LIS1 by wild-type or T131A
mutant NDE1. This demonstrates that residue T131 of NDE1 is
critical for its interaction with LIS1 and that phosphorylation of
this site alters NDE1/LIS1 binding. That there is a difference in
LIS1 binding between wild-type NDE1 and the T131E form,
which simulates constitutively phosphorylated NDE1, also dem-
onstrates that only a proportion of wild-type NDE1 becomes
phosphorylated after IBMX/forskolin treatment.
The previous data demonstrate that T131 influences NDE1/
LIS1 interaction at elevated cAMP levels, thus interaction be-
tween wild-type NDE1 and LIS1 should be sensitive to cellular
cAMP levels. We therefore tested the effect of IBMX/forskolin
treatment of COS7 cells after coimmunoprecipitation of endog-
enous LIS1 with V5-NDE1. Significantly less LIS1 associates with
NDE1 at elevated cAMP levels (p 0.04) (Fig. 5C,D).
NDE1 and NDEL1 are also able to interact with one another
(Burdick et al., 2008; Bradshaw et al., 2009). As stated previously,
bioinformatics analysis suggests that this could occur through
interaction of NDE1 dimers with NDEL1 dimers to form tetram-
ers via their very highly conserved coiled-coil region 3. The three-
dimensional models further predict that the coiling of NDE1
chains to form homotetramers could be affected by phosphory-
lation of T131. This may impact directly on the NDE1/NDEL1
interaction.
To investigate this possibility, COS7 cells were cotransfected
with GFP-tagged NDEL1 and V5-tagged NDE1, either wild type
or carrying the T131A or T131E mutations. GFP-tagged NDEL1
coimmunoprecipitationwithV5-NDE1was then quantified (Fig.
5E,F). The T131E phosphomimic mutant increases the associa-
tion with NDEL1, compared with both the T131A mutant or
wild-typeNDE1, although only the former reached statistical sig-
nificance (p 0.01 and p 0.1, respectively). Most likely this is
caused by basal phosphorylation of wild-type NDE1 at T131.
Phosphorylation/dephosphorylation of T131 may therefore
act as a switch to determinewhetherNDE1 binds preferentially to
LIS1 or NDEL1. Together with prior evidence that endogenously
expressed DISC1/PDE4/NDE1/NDEL1/LIS1 can be coimmuno-
precipitated (Niethammer et al., 2000; Sasaki et al., 2000; Bran-
don et al., 2004; Kamiya et al., 2005; Burdick et al., 2008;
Bradshaw et al., 2009), our data implicate the T131 site and local
cAMP gradients (modulated by DISC1/PDE4), as a mechanism
for regulating NDE1/LIS1/NDEL1 associations, and therefore
function, within the complex.
PKA phosphorylation of T131/T132 during mitosis
During mitosis, LIS1 exits the spindle poles, whereas the concen-
tration of NDE1 and NDEL1 at this location also drops signifi-
cantly (Coquelle et al., 2002; Yan et al., 2003). Given that
phosphorylation of NDE1 at T131 interferes with its binding to
LIS1, we investigated the NDE1/NDEL1 T131/T132 phosphory-
lation status during the cell cycle using the pT131 antibody,
which has the potential to detect both NDE1 and NDEL1 phos-
phorylated at T131 and T132, respectively.
In interphase COS7 cells, antibodies specific for phosphory-
lated T131/T132 (pT131), NDE1, and NDEL1 [EP93 and 231
(Bradshaw et al., 2009)] detected these species at the centrosome,
often more prominently at one centriole than the other (Fig. 6A;
supplemental Fig. 4A,B, available at www.jneurosci.org as sup-
plemental material). During mitosis, the pT131 spindle pole sig-
nal becomes far more abundant (Fig. 6B–E), whereas the spindle
pole signal detected by EP93 and 231 decreases as expected, with
NDE1 becoming virtually undetectable (see supplemental Fig.
4C–F, available at www.jneurosci.org as supplemental material).
During telophase, all three antibodies produced a prominent ad-
ditional signal at the intercellular bridge (Fig. 6F; supplemental
Fig. 4G,H, available at www.jneurosci.org as supplemental
material).
Figure8. NS-1assay to investigate theeffect ofNDE1mutations at T131andS306onneurite
outgrowth. A, Sholl analysis of cells transfectedwithwild type, T131A, or T131E NDE1. Concen-
tric circles, each 10m apart, were centered on the cell bodies of NS-1 cells. Starting from the
first circle outside of the cell body and counting outward, the number of neurites from the cell
that crossed each circle was counted. Only data from the first 11 circles (of 22) are displayed, as
after this point there were n 30 neurites (an average of n 10 per NDE1 category). Vertical
dashed lines indicateoneand two times the lengthof themeancell body (40.5m). *p0.05;
**p0.01.B, A similar analysis of cells transfectedwithwild type, S306A, or S306DNDE1.Only
data from the first 14 circles (of 34) are displayed, as after this point thereweren 30neurites.
Mean cell body length is 58.63m.WT, Wild type.
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PKA-phosphorylated T131/T132 in neurons
To investigate neuronal sites where DISC1/PDE4-mediated reg-
ulation of the NDE1/LIS1/NDEL1 complex by PKA may poten-
tially occur, we used the pT131 antibody to examine brain
fractions and cultured neurons. Previously, we have reported that
NDE1 is present in dendritic spines and accumulates at proximal
axons (Bradshaw et al., 2008). To investigate whether PKA-
phosphorylatedNDE1/NDEL1may also behave in this way, post-
synaptic density fractions from mouse brain lysates were probed
with the pT131 antibody (Fig. 7A). The pT131 signal was en-
riched in the core postsynaptic density fractions relative to the
synaptosomal fraction. To confirm this result, we examined the
expression pattern of pT131 in cultured mouse hippocampal
neurons. We observed that the pT131 signal colocalizes with the
postsynaptic density marker PSD-95 in dendritic spines of ma-
ture hippocampal neurons (Fig. 7B). The pT131 antibody detects
a similar, but in places more enriched, expression pattern in neu-
rites compared with an antibody that detects both NDE1 and
NDEL1, implying that a subpopulation of NDE1/NDEL1 is PKA
phosphorylated (see supplemental Fig. 5A, available at
www.jneurosci.org as supplemental material). Additionally, the
pT131 signal is enriched in the proximal axon of both immature
and mature neurons (Fig. 7C), suggesting a potential role in de-
termining neuronal polarity. However, no significant difference
in localization was seen between neurons expressing wild-type
V5-tagged NDE1 or the T131A or T131E mutants (see supple-
mental Fig. 5B–D, available at www.jneurosci.org as supplemen-
tal material).
NDE1mutants simulating PKA phosphorylation alter
neurite outgrowth
Based on observations that LIS1 and NDEL1 are required for
neurite extension (Nguyen et al., 2004; Kamiya et al., 2006; Duan
et al., 2007; Taya et al., 2007; Shim et al., 2008; Toth et al., 2008;
Youn et al., 2009), we hypothesized that NDE1 may also partici-
pate in neurite outgrowth and that thismay be influenced by PKA
phosphorylation. Rat NS-1 cells were transfected with V5-tagged
NDE1, either wild-type or mutant. After differentiation, neurite
outgrowth was quantified by Sholl analysis. General linear model
repeated-measures analysis demonstrated that the mutation sta-
tus of T131 is significantly associated with the number of neurites
that reach each of a number of concentric circles centered on the
cell body (p 0.0095, F 4.7). For themajority of circles 30–140
m from the cell body, the mean number of neurites was signif-
icantly lower for cells expressing the T131E mutant compared
with those expressing T131A orwild-typeNDE1 (Fig. 8A), as was
the mean total length of neurites per cell (Table 1). However,
there was no significant difference in the number of neurites that
reached the shortest lengths (10–20 m). Together, this implies
that the NDE1 phosphomimic T131E inhibits extension of neu-
rites in NS-1 cells, while not affecting the number of neurites
formed.
The experiment was repeated using S306 nonphosphorylat-
able (S306A) or phosphomimic (S306D)mutants. General linear
model repeated-measures analysis showed no overall effect of the
S306 site on neurite extension (p 0.4, F 0.98 based on the first
21 circles) (Fig. 8B). However, there is evidence that S306 influ-
ences production of neurites, the formation of branch points, and
cell-body elongation (Table 2).
Discussion
Schizophrenia and related affective disorders are genetically
complex disorders that are poorly understood or treated. The
underlying molecular mechanisms are, likewise, poorly under-
stood but are being revealed stepwise through emerging genetic
evidence and biological study. In this regard, the risk factor
DISC1 is a pathfinder (Marx, 2007; Porteous, 2008).
Here, we demonstrate functional interplay between multiple
proteins implicated as risk factors for major mental illness by
showing that DISC1 and PDE4 modulate PKA phosphorylation
ofNDE1 and, in turn, its interactionwith LIS1 andNDEL1. Since
phosphorylated T131 is detectable at multiple subcellular loca-
tions (centrosome, nucleus, postsynaptic density, proximal
axon), there is potential for DISC1/PDE4 to influence several
important brain processes that critically depend on the NDE1/
NDEL1/LIS1 complex.
Centrosomes determine cell polarity and symmetry of neural
progenitor division, regulating maintenance of the neural pro-
genitor pool, and production of new neurons in the brain (Hig-
ginbotham and Gleeson, 2007). Centrosomes are also important
for nucleokinesis as newborn neurons migrate to their final des-
tination in the brain (Higginbotham and Gleeson, 2007). NDE1,
LIS1, and NDEL1 are critically required for these processes (Hi-
rotsune et al., 1998; Feng and Walsh, 2004; Sasaki et al., 2005;
Table 1. Additional measurements taken of NS-1 cells transfected with either wild-type (WT) NDE1 or one of the T131A and T131Emutants
Test
Values p values
WT T131A T131E WT vs T131A WT vs T131E T131A vs T131E
Mean total neurite outgrowth length (m) 88.29 (6.34) 98.97 (9.01) 69.83 (5.15) 0.4 0.02 0.006
Mean number of primary neurites 2.597 (0.109) 2.701 (0.120) 2.475 (0.101) 0.6 0.3 0.15
Mean number of neurite branch points 0.465 (0.066) 0.356 (0.073) 0.383 (0.066) 0.25 0.4 0.8
Mean cell body elongation (ratio) 1.560 (0.044) 1.526 (0.042) 1.576 (0.037) 0.5 0.9 0.4
Mean derived cell area (m2) 836.2 (38.9) 946.0 (42.6) 882.6 (36.6) 0.08 0.45 0.3
Significant p values (p 0.05) obtained from the t test are in bold.
Table 2. Additional measurements taken of NS-1 cells transfected with wild-type (WT) NDE1 or one of the S306A and S306Dmutants
Test
Values p values
WT S306A S306D WT vs S306A WT vs S306D S306A vs S306D
Mean total neurite outgrowth length (m) 148.29 (8.43) 137.00 (8.02) 155.29 (9.79) 0.3 0.65 0.2
Mean number of primary neurites 4.493 (0.172) 4.033 (0.190) 4.843 (0.238) 0.07 0.2 0.009
Mean number of neurite branch points 2.514 (0.223) 1.875 (0.164) 2.436 (0.196) 0.02 0.7 0.04
Mean cell body elongation (ratio) 2.130 (0.097) 2.304 (0.130) 1.912 (0.085) 0.3 0.08 0.01
Mean derived cell area (m2) 1494.2 (82.3) 1427.0 (100.5) 15017 (92.7) 0.6 1 0.6
Significant p values (p 0.05) obtained from the t test are in bold.
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Pawlisz et al., 2008; Yingling et al., 2008), whereas involvement of
DISC1 in neural precursor proliferation and neuronal migration
(Duan et al., 2007; Faulkner et al., 2008; Kvajo et al., 2008; Eno-
moto et al., 2009; Kim et al., 2009; Mao et al., 2009; Niwa et al.,
2010; Singh et al., 2010) and of PDE4 in adult hippocampal neu-
rogenesis (Nakagawa et al., 2002) has also been demonstrated.
Based on these observations, we propose that DISC1/PDE4-
mediated phosphorylation of centrosomal NDE1/NDEL1 at
T131/T132 modulates centrosome-mediated production and
positioning of neurons.
The DISC1/PDE4/NDE1/NDEL1/LIS1 complex likely func-
tions at glutamatergic synapses at the postsynaptic density (Brad-
shaw et al., 2008), but this role is not yet well understood. A role
for DISC1 in modulating dendritic spines and synaptic signaling
has, however, been demonstrated recently (Niwa et al., 2010).
Moreover, LIS1-deficient mice exhibit altered synaptic activity at
glutamatergic synapses, coupled with increased numbers of pre-
synaptic vesicles (Greenwood et al., 2009). Thus, DISC1/PDE4-
mediated PKA phosphorylation of NDE1/NDEL1 could also
modulate LIS1-dependent synaptic function.
Neurite extension is another LIS1, NDEL1-dependent pro-
cess, as demonstrated through a series of studies using RNA in-
terference andmice deficient in expression of these genes (Taya et
al., 2007; Shim et al., 2008; Mori et al., 2009; Youn et al., 2009).
Indeed, NDEL1 phosphorylation by Aurora-A kinase is an essen-
tial requirement for neurite elongation (Mori et al., 2009). We
now demonstrate using NDE1 phospho-mimics that the phos-
phorylation status of T131 influences neurite outgrowth. DISC1/
PDE4-modulated PKA phosphorylation consequently has the
potential to influence many important neural processes through
effects on the NDE1/NDEL1/LIS1 complex.
We predict that formation andmaintenance of DISC1/PDE4/
NDE1/NDEL1/LIS1 multiprotein complexes is regulated by al-
terations in cAMP levels. It is known that DISC1/PDE4B and
DISC1/PDE4D complexes are disrupted in response to elevation
of cAMP levels (Millar et al., 2005a; Murdoch et al., 2007). Fur-
thermore, PDE4D/NDEL1 interaction is modulated by PKA
phosphorylation of PDE4D3 within its unique N terminus (Col-
lins et al., 2008). We have now demonstrated that LIS1/NDE1
and NDE1/NDEL1 interaction is modulated by PKA phosphor-
ylation of NDE1 at position T131. We speculate that PKA phos-
phorylation of selected proteins within the complex dynamically
alters the binding constants, and thus stoichiometry, of complex
components, alternately exposing and masking phosphorylation
and interaction sites, in time and space, to sequester and com-
partmentalize signaling pathways.
The t(1;11) and t(1;16) translocations that first identified
DISC1 and PDE4B, respectively, as risk factors for psychiatric
disorders result in reduced protein expression (Millar et al.,
2005a). The common DISC1 coding variant S704C is associated
with psychiatric disorders and brain structure/function (Callicott
et al., 2005; Hashimoto et al., 2006; Qu et al., 2007; Di Giorgio et
al., 2008; Song et al., 2008). This variant alters DISC1 oligomer-
ization (Leliveld et al., 2009) and binding to NDE1/NDEL1 (Ka-
miya et al., 2006; Burdick et al., 2008). Putative “ultra-rare”
causal mutations in DISC1 have also been identified (Song et al.,
2008).One of thesemutations, R37W, is locatedwithin a PDE4B-
specific binding site and may therefore alter DISC1/PDE4 bind-
ing. NDEL1 and NDE1 have also been implicated as risk factors
formajormental illness (Hennah et al., 2007; Burdick et al., 2008;
Ingason et al., 2009; Need et al., 2009; Tomppo et al., 2009;
Nicodemus et al., 2010) although causal mutations await identi-
fication. There is thus potential for dysregulation of the DISC1/
PDE4/NDE1/NDEL1/LIS1multiprotein complex in the brains of
psychiatric patients by several mechanisms. Reduced levels of
DISC1 or PDE4 in the complex, or functional mutations in
DISC1, are predicted to result in altered local cAMP levels,
through the cAMP phosphodiesterase activity of PDE4- and
DISC1-mediated modulation of this activity. The resulting dys-
regulation of PKA signaling will, in turn, influence protein inter-
actions within the complex and its function within the
developing and adult brain, impacting on the risk of schizophre-
nia and related psychiatric illness.
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